Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Cross-Regional Radiomic Consistency In Squamous Cell Carcinoma: Common PET/CT Features and Their Prognostic Value

Abstract
Purpose

Radiomics enables quantitative characterization of tumors from PET and CT imaging. When anatomic-region-specific cancer data are limited, transfer and semi-supervised learning can improve prediction by leveraging data from different regions; however, the basis of such transferability remains underexplored. Squamous cell carcinoma (SCC) occurs in both lung and head and neck (HN) cancers and shares a common histopathological origin, suggesting potential radiomic commonalities. This study identifies shared PET and CT-derived radiomic features (RFs) between lung and HN SCC, and evaluates their prognostic value for survival prediction.

Methods

PET and CT images from 42 lung-SCC patients and 42 HN-SCC patients were randomly selected from multicenter datasets, including TCIA Radiogenomics, TCGA, BC-Cancer, and HECKTOR challenge. PET images were SUV-normalized, and CT images were intensity-clipped before analysis. Tumor regions of interest were used to extract 107 RFs by PyRadiomics, including first-order, shape-based, and texture features. Feature distributions were compared between cancer types within each modality using the Mann-Whitney-U-test. Survival outcome prediction (good vs. poor) was performed using 11 classifiers for HN-CT, lung-CT, HN-PET, and lung-PET. Feature importance for each of the four prediction tasks was then assessed using SHapley Additive exPlanations analysis (SHAP).

Results

Thirteen PET- and nine CT-RFs showed no significant distributional differences between lung- and HN-SCC (p>0.05). In PET imaging, three shared first-order features (mean, 90th percentile, and total energy) ranked among the top predictors of outcome, whereas only one CT feature (90th percentile) demonstrated comparable importance. For lung-SCC, the best predictive performance was achieved with AUC=0.68±0.17 with Multilayer Perceptron (MLP) for PET and 0.68±0.10 with Gradient Boosting for CT. In HN-SCC, CT achieved AUC=0.87±0.10 with MLP, while PET reached AUC=0.80±16 using Random Forest.

Conclusion

Shared PET-RFs across lung- and HN-SCC may support semi-supervised and transfer learning by enabling transferable modeling with unlabeled data, improving cross-cancer prognostic prediction.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested